ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 267.48B
Enterprise Value 321.52B
Trailing P/E 35.12
Forward P/E 13.70
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.68
Price/Book (mrq)15.26
Enterprise Value/Revenue 5.67
Enterprise Value/EBITDA 24.45

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 3-6.66%
S&P500 52-Week Change 31.77%
52 Week High 3168.11
52 Week Low 3134.09
50-Day Moving Average 3153.70
200-Day Moving Average 3150.73

Share Statistics

Avg Vol (3 month) 35.71M
Avg Vol (10 day) 35.27M
Shares Outstanding 51.76B
Implied Shares Outstanding 6N/A
Float 81.76B
% Held by Insiders 10.13%
% Held by Institutions 171.46%
Shares Short (May 14, 2023) 411.97M
Short Ratio (May 14, 2023) 42.2
Short % of Float (May 14, 2023) 40.68%
Short % of Shares Outstanding (May 14, 2023) 40.68%
Shares Short (prior month Apr 13, 2023) 415.14M

Dividends & Splits

Forward Annual Dividend Rate 45.92
Forward Annual Dividend Yield 44.30%
Trailing Annual Dividend Rate 35.78
Trailing Annual Dividend Yield 34.17%
5 Year Average Dividend Yield 44.44
Payout Ratio 4134.35%
Dividend Date 3May 14, 2023
Ex-Dividend Date 4Apr 12, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 13.37%
Operating Margin (ttm)36.98%

Management Effectiveness

Return on Assets (ttm)9.44%
Return on Equity (ttm)51.28%

Income Statement

Revenue (ttm)56.74B
Revenue Per Share (ttm)32.04
Quarterly Revenue Growth (yoy)-9.70%
Gross Profit (ttm)41.53B
Net Income Avi to Common (ttm)7.54B
Diluted EPS (ttm)4.25
Quarterly Earnings Growth (yoy)-94.70%

Balance Sheet

Total Cash (mrq)6.72B
Total Cash Per Share (mrq)3.81
Total Debt (mrq)62.46B
Total Debt/Equity (mrq)469.53
Current Ratio (mrq)0.96
Book Value Per Share (mrq)7.53

Cash Flow Statement

Operating Cash Flow (ttm)24.23B
Levered Free Cash Flow (ttm)21.6B